Stem Cell Transplant Slows Progression of Multiple Sclerosis

TUESDAY, Jan. 15, 2019 -- For patients with relapsing-remitting multiple sclerosis (MS), nonmyeloablative hematopoietic stem cell transplantation (HCST) is associated with prolonged time to disease progression compared with disease-modifying therapy...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news